Alyeska Investment Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Hold
275,000
0.03% 412
2026
Q1
$10.4M Buy
+275,000
New +$8.98M 0.03% 396
2025
Q4
Sell
-207,393
Closed -$5.44M 760
2025
Q3
$5.44M Sell
207,393
-571,177
-73% -$13.6M 0.02% 448
2025
Q2
$16.6M Buy
778,570
+350,000
+82% +$7.9M 0.06% 300
2025
Q1
$9.11M Hold
428,570
0.04% 318
2024
Q4
$8.68M Hold
428,570
0.03% 351
2024
Q3
$7.2M Buy
+428,570
New +$7.22M 0.04% 319

Other funds holding GRDN

Alyeska Investment Group's GRDN Position: Q2 2026 in Review

Alyeska Investment Group held its Guardian Pharmacy Services (GRDN) position steady in Q2 2026 at 275,000 shares worth $11.5M. The position accounts for 0.03% of the portfolio, ranked #412.

Alyeska Investment Group first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $16.6M in Q2 2025. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Alyeska Investment Group held 275,000 shares of Guardian Pharmacy Services worth $11.5M as of Q2 2026.
  • Alyeska Investment Group left its Guardian Pharmacy Services share count unchanged in Q2 2026.
  • Guardian Pharmacy Services made up 0.03% of Alyeska Investment Group's portfolio in Q2 2026, its #412 holding.
  • Alyeska Investment Group first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Alyeska Investment Group's Guardian Pharmacy Services position peaked at $16.6M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.